Organization
Smilebiotek Zhuhai
2 clinical trials
Clinical trial
A Phase 2, Double-Masked, Randomized, Placebo-Controlled, Dose-Response Study Assessing the Safety and Efficacy of QA102 in Subjects With Dry Age-Related Macular Degeneration (AMD)Status: Active (not recruiting), Estimated PCD: 2025-01-01
Clinical trial
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase II Clinical Study of the Efficacy and Safety of QA108 Granules in the Treatment of Intermediate Age-Related Macular DegenerationStatus: Recruiting, Estimated PCD: 2024-03-30